Operating Lease, Right-of-Use Asset of REGENEREX PHARMA, INC. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: REGENEREX PHARMA, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
REGENEREX PHARMA, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $527,235, a 16% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$527,235	-$98,444	-16%	30 Sep 2025	10-Q	17 Nov 2025	2025	Q2
Q2 2025	$566,353	-$154,099	-21%	30 Jun 2025	10-Q	14 Aug 2025	2024	Q1
Q1 2025	$604,262	-$152,081	-20%	31 Mar 2025	10-Q	17 Nov 2025	2025	Q2
Q4 2024	$641,075	-$193,218	-23%	31 Dec 2024	10-Q	07 Feb 2025	2024	Q3
Q3 2024	$625,679	-$277,907	-31%	30 Sep 2024	10-Q	04 Nov 2024	2024	Q2
Q2 2024	$720,452	-$219,896	-23%	30 Jun 2024	10-Q	07 Aug 2024	2024	Q1
Q1 2024	$756,343			31 Mar 2024	10-K	30 Jun 2025	2024	FY
Q4 2023	$834,293			31 Dec 2023	10-Q	05 Feb 2024	2023	Q3
Q3 2023	$903,586			30 Sep 2023	10-Q	08 Nov 2023	2023	Q2
Q2 2023	$940,348			30 Jun 2023	10-Q	14 Aug 2023	2023	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.